Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer

European Journal of Nuclear Medicine

Volumn 29, Issue 10, 2002, Pages 1380-1384

  Kotzerke, Jörg ^a,b   Volkmer, Björn G ^a,b   Neumaier, Bernd ^a,b   Gschwend, Jürgen E ^a,b   Hautmann, Richard E ^a,b   Reske, Sven N ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Acetate; Positron emission tomography; Prostate cancer; Recurrence

Indexed keywords

ACETIC ACID C 11; PROSTATE SPECIFIC ANTIGEN; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; CARBON 11;

ABDOMEN; ADULT; AGED; ARTICLE; BLADDER; BONE METASTASIS; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; RADIODIAGNOSIS; TRANSRECTAL ULTRASONOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEASIBILITY STUDY; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; CANCER PATIENT; PROSTATE CANCER;

ACETATES; AGED; AGED, 80 AND OVER; CARBON; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036383492     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0882-6     Document Type: Article

References (10)

1. Fichtner J, Miller K. Das Management von Patienten mit steigenden PSA-Werten nach kurativer Therapie. Urologe A 2000; 39:475-482.
2. Pisansky TM, Kozelsky TF, Myers RP, et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 2000; 163:845-850.
3. 11C-Acetate PET imaging of prostate cancer. J Nucl Med 2002; 43:181-186.
4. Shreve P, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995; 36:1595-1601.
5. 11C-acetate clearance in nasopharyngeal carcinoma. Nucl Med Commun 1999; 20:131-134.
6. Dienel GA, Popp D, Drew PD, Ball K, Krisht A, Cruz NF. Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate. J Nucl Med 2001; 42:1243-1250.
7. Yoshimoto M, Waki A, Yonekura Y, et al. Characterization of acetate metabolism in tumour cells in relation to cell proliferation: acetate metabolism in tumour cells. Nucl Med Biol 2001; 28:117-122.
8. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998; 39:990-995.
9. Kotzerke J, Prang J, Neumaier B, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 2000; 27:1415-1419.
10. 18F]FECh) for cancer imaging with PET: synthesis, biochemistry and prostate cancer imaging. J Nucl Med 2002; 43:187-199.